Skip to Main Content

Author Details

Susan J Johns
Center for Visualization, Washington State University
1992
38
26
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
22231567Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3.Pharmacogenomics J2013
23085876The UCSF-FDA TransPortal: a public drug transporter database.Clin Pharmacol Ther2012
21368754Functional characterization of liver enhancers that regulate drug-associated transporters.Clin Pharmacol Ther2011
21956618A common 5'-UTR variant in MATE2-K is associated with poor response to metformin.Clin Pharmacol Ther2011
20668102Genetic variants of human organic anion transporter 4 demonstrate altered transport of endogenous substrates.Am J Physiol Renal Physiol2010
20859243Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin.Pharmacogenet Genomics2010
19098160Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 (SLC28A2).J Pharmacol Exp Ther2009
19745787Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1.Pharmacogenet Genomics2009
19742321Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation.PLoS One2009
19172157Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function.Pharmacogenomics J2009
19141711Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).J Pharmacol Exp Ther2009
18364470The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene.J Pharmacol Exp Ther2008
17700366Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4).Pharmacogenet Genomics2007
16381950The International Gene Trap Consortium Website: a portal to all publicly available gene trap cell lines in mouse.Nucleic Acids Res2006
16702441Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants.J Pharmacol Exp Ther2006
16507879PharmGKB submission update: VI. PMT submissions of genetic variations in neurotransmitter transporters (SLC6, SLC17, and SLC18) to the PharmGKB network.Pharmacol Rev2006
16507878PharmGKB submission update: V. PMT submissions of genetic variation in SLC22 family transporters.Pharmacol Rev2006
16507877PharmGKB submission update: IV. PMT submissions of genetic variations in ATP-Binding cassette transporters to the PharmGKB network.Pharmacol Rev2006
16214850Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2.Drug Metab Dispos2006
16291576The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics.Am J Physiol Renal Physiol2006
15738947Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3).Pharmacogenomics J2005
15864112Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1).Pharmacogenet Genomics2005
15861032Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2.Pharmacogenet Genomics2005
15169925PharmGKB update: III. Genetic variants of SLC22A1, solute carrier family 22 (organic cation transporter), member 1.Pharmacol Rev2004
14978229Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations.Mol Pharmacol2004
12520002BayGenomics: a resource of insertional mutations in mouse embryonic stem cells.Nucleic Acids Res2003
12893986Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.Pharmacogenetics2003
12869664PharmGKB update: I. Genetic variants of the organic cation transporter 2 (OCT2, SLC22A2).Pharmacol Rev2003
12603056SNP analysis and presentation in the Pharmacogenetics of Membrane Transporters Project.Pac Symp Biocomput2003
12724623Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1.Pharmacogenetics2003
12719534Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1.Proc Natl Acad Sci U S A2003
12719533Natural variation in human membrane transporter genes reveals evolutionary and functional constraints.Proc Natl Acad Sci U S A2003
12142729Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function.Pharmacogenetics2002
11741257Genomic structure of proton-coupled oligopeptide transporter hPEPT1 and pH-sensing regulatory splice variant.AAPS PharmSci2001
11331016Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3.Biochemistry2001
9390246An introductory course in computation molecular biology: rationale, history, observations, and course description.Pac Symp Biocomput1996
7484422Angiotensin II receptors. Structural and functional considerations.Adv Exp Med Biol1995
1579571Use of conditional probabilities for determining relationships between amino acid sequence and protein secondary structure.Proteins1992
  • 1 - 38 of 38

Recommended Authors

Department of Pharmacy and Science for Life Laboratory, Uppsala University
Career Start Year 2018
Number of shared co-authors 9
University of California san francisco
Career Start Year 2018
Number of shared co-authors 8
Schools of Pharmacy and Medicine, University of California san francisco
Career Start Year 2013
Number of shared co-authors 8
University of California San Francisco
Career Start Year 2009
Number of shared co-authors 6
University of California San Francisco
Career Start Year 2009
Number of shared co-authors 8
University of California San Francisco
Career Start Year 2007
Number of shared co-authors 9
Stanford University
Career Start Year 2007
Number of shared co-authors 6
Stanford University
Career Start Year 2004
Number of shared co-authors 6
Vanderbilt University
Career Start Year 2004
Number of shared co-authors 8
Qatar University
Career Start Year 2004
Number of shared co-authors 0
Stanford Cardiovascular Institute (L.W., Stanford University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
University of Washington
Career Start Year 2001
Number of shared co-authors 7
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
Center for Pharmacogenomics and Precision Medicine, University of Florida
Career Start Year 1998
Number of shared co-authors 4
University of California
Career Start Year 1996
Number of shared co-authors 0
Institucio Catalana de Recerca i Estudis Avancats (ICREA)
Career Start Year 1996
Number of shared co-authors 1
University of California
Career Start Year 1996
Number of shared co-authors 0
and of Biochemistry and Pharmacy, University of Tuebingen
Career Start Year 1996
Number of shared co-authors 5
and University of Tuebingen, University of Tuebingen
Career Start Year 1995
Number of shared co-authors 2
Center for Biologics Evaluation and Research
Career Start Year 1991
Number of shared co-authors 0
University Hospital Munster
Career Start Year 1989
Number of shared co-authors 2
Conway Institute of Biomolecular and Biomedical Research, University College Dublin
Career Start Year 1987
Number of shared co-authors 1
Stanford University
Career Start Year 1986
Number of shared co-authors 14
Australian Institute of Tropical Health and Medicine, James Cook University
Career Start Year 1982
Number of shared co-authors 0
Stanford University
Career Start Year 1982
Number of shared co-authors 16
National Cancer Institute
Career Start Year 1980
Number of shared co-authors 2
Center for Precision Medicine and Functional Genomics, Utah Tech University
Career Start Year 1979
Number of shared co-authors 11
and Blood Institute, National Institutes of Health
Career Start Year 1978
Number of shared co-authors 0
The Rockefeller University
Career Start Year 1976
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1968
Number of shared co-authors 6

Collaborators

University of California San Francisco
Co-authored papers 32
University of California San Francisco
Co-authored papers 32
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 32
Co-authored papers 25
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 22
University of California san francisco
Co-authored papers 16
University of Toledo
Co-authored papers 15
University of California san francisco
Co-authored papers 11
University of California San Francisco
Co-authored papers 8
University of California San Francisco
Co-authored papers 8
Victor Chang Cardiac Research Institute
Co-authored papers 7
University of California San Francisco (UCSF)
Co-authored papers 7
Cardiovascular Research Institute, University of California San Francisco
Co-authored papers 7
Eshelman School of Pharmacy, University of North Carolina
Co-authored papers 6
Co-authored papers 5
Children's Hospital Oakland Research Institute
Co-authored papers 4
University of California San Francisco
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
College of Medicine, Ewha Womans University
Co-authored papers 3
University of California san francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3
Tsinghua University
Co-authored papers 3
Amunix Pharmaceuticals
Co-authored papers 2
Department of Drug Metabolism and Pharmacokinetics, Inc.
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Sapporo Medical University
Co-authored papers 2
Cardiovascular Research Institute, University of California san francisco
Co-authored papers 2
Wellcome Trust Sanger Institute
Co-authored papers 2